Skip to main content
Premium Trial:

Request an Annual Quote

Incyte to Market Drug Profiling System from MDS Pharma and Iconix

NEW YORK, Dec. 12 — MDS Pharma Services and Iconix Pharmaceuticals announced Wednesday an agreement to develop a new system to evaluate drug efficacy and toxicity. The system, called DrugMatrix, will combine chemical, genomic, and pharmacological information to allow for rapid profiling of drug candidates. Incyte, which entered an agreement with and made an equity investment in Iconix in May 2001, will commercialize the new platform.

The two firms will collaborate on developing the system. Montreal-based MDS Pharma Services will make an equity investment in Iconix of Mountain View, Calif., and commit additional money and resources to the development partnership. Other financial details of the partnership were not disclosed.

MDS Pharma Services will profile thousands of benchmark drug molecules to create a standardized source of comprehensive pharmacological information on both successful and unsuccessful drug candidates. Iconix will provide genomic expression array profiling and chemical indexing of the molecules.

Privately held Iconix is known for its work in the field of “chemogenomics,” the effort to connect genomic data with information about pharmacology, toxicology and drug molecule structure.

Iconix integrated Incyte’s LifeExpress Lead database into its current chemogenomics system. Incyte has exclusive marketing rights to the new platform.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.